We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+3.23%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$472B
AUM Growth
+$3.53B
Cap. Flow
-$5.2B
Cap. Flow %
-1.1%
Top 10 Hldgs %
16.24%
Holding
2,596
New
95
Increased
1,094
Reduced
954
Closed
84

Top Buys

Rank Stock Value
1
MDLZ icon
Mondelez International
MDLZ
+$841M
2
LBTYK icon
Liberty Global Class C
LBTYK
+$752M
3
AAPL icon
Apple
AAPL
+$720M
4
TSLA icon
Tesla
TSLA
+$713M
5
NXPI icon
NXP Semiconductors
NXPI
+$648M

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$1.2B
2
AGN
Allergan plc
AGN
+$1.03B
3
GILD icon
Gilead Sciences
GILD
+$917M
4
PFE icon
Pfizer
PFE
+$901M
5
NKE icon
Nike
NKE
+$872M

Sector Composition

Rank Sector Weight
1 Healthcare 19.88%
2 Consumer Discretionary 14.86%
3 Financials 14.2%
4 Technology 12.51%
5 Industrials 9.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CENX icon
2501
Century Aluminum
CENX
$4.77B
– –
-23,800
Closed -$168K
CG icon
2502
Carlyle Group
CG
$17.2B
– –
-309,200
Closed -$5.22M
CHGG icon
2503
Chegg
CHGG
$88.9M
– –
-17,937
Closed -$80K
CNVS icon
2504
Cineverse
CNVS
$68.9M
– –
-314
Closed -$13K
CORT icon
2505
Corcept Therapeutics
CORT
$12.1B
– –
-100,454
Closed -$470K
DBC icon
2506
Invesco DB Commodity Index Tracking Fund
DBC
$1.73B
– –
-28,000
Closed -$372K
EIDO icon
2507
iShares MSCI Indonesia ETF
EIDO
$492M
– –
-573,900
Closed -$13.5M
EWA icon
2508
iShares MSCI Australia ETF
EWA
$1.46B
– –
-12,200
Closed -$236K
EWL icon
2509
iShares MSCI Switzerland ETF
EWL
$2.22B
– –
-9,000
Closed -$268K
FWONA icon
2510
Liberty Media Series A
FWONA
$23.7B
– –
-64,090
Closed -$1.67M
FWONK icon
2511
Liberty Media Series C
FWONK
$26B
– –
-141,942
Closed -$3.83M
KT icon
2512
KT
KT
$8.83B
– –
-482,400
Closed -$6.47M
MEOH icon
2513
Methanex
MEOH
$4.17B
– –
-513,922
Closed -$16.5M
MOV icon
2514
Movado Group
MOV
$815M
– –
-7,380
Closed -$203K
NCMI icon
2515
National CineMedia
NCMI
$209M
– –
-37,929
Closed -$5.77M
RAIL icon
2516
FreightCar America
RAIL
$243M
– –
-21,230
Closed -$331K
SMCI icon
2517
Super Micro Computer
SMCI
$24.3B
– –
-70,900
Closed -$242K
TNK icon
2518
Teekay Tankers
TNK
$2.81B
– –
-7,530
Closed -$221K
WASH icon
2519
Washington Trust Bancorp
WASH
$750M
– –
-445,309
Closed -$16.6M
WHG icon
2520
Westwood Holdings Group
WHG
$183M
– –
-3,620
Closed -$212K
XOMA
2521
DELISTED
Xoma
XOMA
– –
-3,873
Closed -$60K
CNH
2522
CNH Industrial
CNH
$17.3B
– –
-147,876
Closed -$870K
ATYR
2523
aTyr Pharma
ATYR
$53M
– –
-37,175
Closed -$2.05M
TTOO
2524
DELISTED
T2 Biosystems, Inc
TTOO
– –
-68
Closed -$3.33M
BNFT
2525
DELISTED
Benefitfocus, Inc.
BNFT
– –
-81,012
Closed -$2.7M
99 100
101
102 103

Similar funds

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

T. Rowe Price Associates's Q2 2016 Portfolio in Review

As of Q2 2016, T. Rowe Price Associates held 2,596 positions worth $472B, up 0.75% from $468B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

T. Rowe Price Associates's Q2 2016 filing shows 95 new, 1,094 increased, 954 reduced and 84 closed positions. Its largest new stake was American Tower Corporation: 2,223,765 shares worth $246M. The largest sale was Alexion Pharmaceuticals, an estimated $1.2B.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Financials.

  • T. Rowe Price Associates's largest Q2 2016 buy was American Tower Corporation: 2,223,765 shares worth $246M.
  • T. Rowe Price Associates added most to Mondelez International in Q2 2016, an estimated $841M increase.
  • T. Rowe Price Associates's biggest Q2 2016 reduction was Alexion Pharmaceuticals, cutting an estimated $1.2B.
  • T. Rowe Price Associates fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $750M.
  • T. Rowe Price Associates's ten largest holdings make up 16% of its $472B portfolio in Q2 2016.
  • T. Rowe Price Associates opened 95 new positions and closed 84 in Q2 2016.
  • T. Rowe Price Associates's portfolio value rose 0.75% quarter-over-quarter to $472B.

Based on T. Rowe Price Associates's 13F filing for Q2 2016, filed 15 Aug 2016.